Physician profile
Ernest E Jones
NPI 1891705661
$1,924.03
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $280.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $304.52 | 2019-2020 | |
| Pfizer INC. | $273.66 | 2019-2020 | |
| Novo Nordisk INC | $198.57 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.93 | 2019-2020 | |
| Inspire Medical Systems, INC. | $138.17 | 2019 | |
| Amgen INC. | $130.04 | 2019-2020 | |
| Amarin Pharma, INC. | $126.43 | 2019 | |
| Mylan Specialty L.P. | $88.56 | 2019-2020 | |
| Astellas Pharma US INC | $78.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $78.03 | 2019-2020 | |
| Abbvie INC. | $75.21 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $55.84 | 2019 | |
| Glaxosmithkline, LLC. | $51.76 | 2019 | |
| Radius Health, INC. | $41.13 | 2019 | |
| Sanofi Pasteur INC. | $32.91 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $30.58 | 2019-2020 | |
| Therapeuticsmd, INC. | $28.58 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.98 | 2019 | |
| Allergan, INC. | $12.19 | 2019 | |
| Lilly USA, LLC | $11.31 | 2019 | |
| Vertiflex, INC. | $11.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ernest Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.